VCENNA, established in 2019 and headquartered in Canada, is a pioneering company in the Biotechnology and Health and Wellness industries. The company's slogan, "Natural Neuro-Pharmaceutical Discovery for Mental Wellness & CNS Disorders," succinctly captures its mission to revolutionize mental health treatment using advanced drug discovery techniques.
Focused on the burgeoning field of psychedelic medicine, VCENNA is strategically positioned to explore the pharmacological benefits of natural psychedelic extracts. They utilize cutting-edge research methodologies to map the effects of these compounds, aiming to create innovative solutions for mental wellness and central nervous system disorders.
As of the latest available information, VCENNA has not disclosed any recent investment rounds or investor participation. This presents a potential opportunity for venture capitalists interested in investing in a promising biotech startup at an early stage.